BioSig Technologies, Inc. STEX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 1.7×+1.5× | 0.2×+0.1× | 0.1×-0.2× | 0.3×-5.0× | |
| Per Share | |||||
| Book value per share | $2.78+2,624% | -$0.11+73.2% | -$0.41-665% | $0.07— | |
| Valuation | |||||
| Market capitalization | $88.66M-61.8% | $25.68M-39.8% | $42.66M+89.1% | $22.56M-71.3% | |
| Price / book | 0.6×— | —— | —— | 72.1×+65.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioSig Technologies, Inc.'s profit margins?
- BioSig Technologies, Inc. (STEX) runs a 80.1% gross margin and a -32155.0% operating margin, with a -25825.0% net margin.
- Where do BioSig Technologies, Inc.'s ratios come from?
- Every ratio is computed from BioSig Technologies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
